News Sentiment

STAA sentiment intelligence

STAAR Surgical Company news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 54 Balanced news tone 47 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Medical Instruments & Supplies Read-through group
Latest close 27.76 Week of 10 Jul 2026
Weighted tone 54/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

79/100 classification confidence.

Company focus 47

directly relevant articles

Source quality 2

high-authority source matches

Trend context Trend active

-0.1% over one week, -2.2% over four weeks, trend active, and near fair-value range.

Latest direct headline Neutral

Staar Surgical's China ICL Demand Driven by Macro Affordability Pressures, Wedbush Says

Market Reaction

Balanced read

52/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 79/100 classification
One-week reaction -0.1% Price digesting
Trend fit Trend active -2.2% over four weeks
Fair value -6.1% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 12
Neutral 33
Negative 2

Relevance

Why the article matched

Direct first
Direct company coverage 47
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 8
Market source 7
StockStory 4
TradingView 4
Stock Traders Daily 2
Simply Wall Street 2
The Globe and Mail 2
Investing.com Canada 2

Event Lens

What the news is about

Classified themes
Market update 25
Earnings 10
Analyst action 5
Deals and strategy 3
Macro sensitivity 1
Guidance 1
Regulatory and legal 1
Balance sheet 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 47
Stock Traders Daily Direct company coverage

Trading Systems Reacting to (STAA) Volatility

Staar Surgical Company (NASDAQ: STAA) is exhibiting weak near and mid-term sentiment, potentially pressuring a neutral long-term outlook. AI models have generated three distinct trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—to capitalize on a mid-channe

Tone
Neutral 50/100
Event
Guidance
Published
10 Jul 2026 04:10
Source
Stock Traders Daily
Stocktwits Direct company coverage

STAA Stock On Track For Its Fourth Straight Session Of Gains – This Analyst Would Rather Be Early Than Late On Staar’s Growth Story

Shares of Staar Surgical (STAA) rose over 10% after strong first-quarter results led multiple analysts to issue bullish ratings. Wedbush upgraded STAA to 'Outperform' with a $40 price target, citing a potential full China rebound and long-term growth exceeding expectations. Canac

Tone
Positive 87/100
Event
Analyst action
Published
09 Jul 2026 16:10
Source
Stocktwits
Ophthalmology Times Direct company coverage

Heidelberg Engineering, STAAR, Ziemer to showcase latest technologies at ESCRS 2025

Heidelberg Engineering, STAAR Surgical, and Ziemer Ophthalmic Systems are set to present their latest advancements in cataract and refractive surgery at the 43rd ESCRS Congress in Copenhagen. Heidelberg Engineering will launch a new ANTERION software update with improved cataract

Tone
Neutral 50/100
Event
Market update
Published
08 Jul 2026 01:09
Source
Ophthalmology Times
AD HOC NEWS Direct company coverage

STAAR Surgical Co highlights its vision correction technology as investors weigh long-term growth

STAAR Surgical Co (ISIN US8577001096) specializes in implantable collamer lenses for refractive vision correction, positioning itself in the growing market for advanced eye surgery. The company's business model focuses on supplying high-value medical devices to eye care professio

Tone
Positive 71/100
Event
Market update
Published
07 Jul 2026 14:47
Source
AD HOC NEWS
StockStory Direct company coverage

3 Reasons to Avoid STAA and 1 Stock to Buy Instead

This article recommends avoiding STAAR Surgical (STAA) despite its recent stock gains, citing three main reasons: declining revenue, a dropping free cash flow margin, and a decrease in Return on Invested Capital (ROIC). The author suggests better investment opportunities exist an

Tone
Negative 18/100
Event
Earnings
Published
02 Jul 2026 19:09
Source
StockStory
Stock Traders Daily Direct company coverage

How Staar Surgical Company (STAA) Affects Rotational Strategy Timing

This article analyzes Staar Surgical Company (STAA) through an AI model, revealing strong near-term sentiment but neutral mid and long-term outlooks. It highlights a significant short setup with a 67.7:1 risk-reward ratio targeting a 19.2% downside. The analysis provides three in

Tone
Neutral 50/100
Event
Market update
Published
29 Jun 2026 03:28
Source
Stock Traders Daily
TradingView Direct company coverage

STAAR Surgical Company Actuals & Estimates (NASDAQ:STAA)

This article provides an overview of STAAR Surgical Company (NASDAQ: STAA) financial performance, stock price data, and analyst forecasts. It covers key metrics such as current stock price, historical highs and lows, market capitalization, volatility, and details on its latest ea

Tone
Positive 70/100
Event
Analyst action
Published
26 Jun 2026 03:40
Source
TradingView
TradingView Direct company coverage

Price to book forward of STAAR Surgical Company – NASDAQ:STAA

This page provides financial data for STAAR Surgical Company (NASDAQ: STAA), specifically focusing on its price-to-book forward ratio. The content seems to be an excerpt from a financial data platform, likely TradingView, presenting the stock's financial overview without detailed

Tone
Neutral 50/100
Event
Market update
Published
26 Jun 2026 03:27
Source
TradingView
Simply Wall Street Direct company coverage

What STAAR Surgical (STAA)'s New Shelf Registration and Equity Plan Expansion Means For Shareholders

STAAR Surgical (STAA) recently filed a US$110.604 million shelf registration for 3,900,000 common shares and expanded its Omnibus Equity Incentive Plan by the same amount following shareholder approval. This move aims to provide financial flexibility and align leadership incentiv

Tone
Neutral 50/100
Event
Regulatory and legal
Published
25 Jun 2026 12:39
Source
Simply Wall Street
The Globe and Mail Direct company coverage

Staar Surgical Shareholders Approve Expanded Equity Incentive Plan

Staar Surgical shareholders approved an expanded equity incentive plan, reserving an additional 3.9 million shares for issuance, during their 2026 Annual Meeting. They also re-elected seven directors and ratified BDO USA, P.C. as the independent registered public accounting firm.

Tone
Positive 66/100
Event
Market update
Published
24 Jun 2026 17:09
Source
The Globe and Mail
Stock Titan Direct company coverage

Director of STAAR Surgical (NASDAQ: STAA) receives grant of 11,145 stock options

Christopher Min Fang Wang, a director of STAAR Surgical (NASDAQ: STAA), was granted 11,145 stock options with an exercise price of $29.12 per share. These options are part of his compensation, not an open-market transaction, and will vest fully on the earlier of June 18, 2027, or

Tone
Neutral 50/100
Event
Market update
Published
23 Jun 2026 20:40
Source
Stock Titan
Investing.com Canada Direct company coverage

Form 4 STAAR Surgical Company For: 23 June By Investing.com

This article reports on a Form 4 filing for STAAR Surgical Company (STAA) dated June 23. This financial filing indicates insider transactions or changes in beneficial ownership. The article also provides key market data, including various indices, commodities, and stock performan

Tone
Neutral 50/100
Event
Market update
Published
23 Jun 2026 20:40
Source
Investing.com Canada
Stock Titan Direct company coverage

Director Neal Bradsher granted 11,145 STAAR Surgical (STAA) stock options

STAAR Surgical director Neal C. Bradsher received a grant of 11,145 stock options as director compensation. The options have an exercise price of $29.12 per share and will expire on June 18, 2036. They will vest on the earlier of June 18, 2027, or the company's next annual shareh

Tone
Neutral 50/100
Event
Market update
Published
23 Jun 2026 03:40
Source
Stock Titan
Investing.com Canada Direct company coverage

Form 4 STAAR Surgical Company For: 22 June By Investing.com

This article reports on the filing of a Form 4 for STAAR Surgical Company on June 22nd, as noted by Investing.com. A Form 4 is a document that must be filed with the U.S. Securities and Exchange Commission (SEC) whenever there is a change in the beneficial ownership of a company'

Tone
Neutral 50/100
Event
Market update
Published
23 Jun 2026 00:11
Source
Investing.com Canada
Stock Titan Direct company coverage

STAAR Surgical (STAA) director awarded 11,145 stock options at $29.12 strike

STAAR Surgical director Richard T. LeBuhn was granted 11,145 stock options at an exercise price of $29.12 per share as part of his director compensation. These options will vest by June 18, 2027, or the company's next annual shareholder meeting, contingent on his continued servic

Tone
Neutral 50/100
Event
Market update
Published
22 Jun 2026 23:11
Source
Stock Titan
Barchart.com Direct company coverage

Intraocular Lens Market to Witness Transformational Growth Opportunities by 2032 – DelveInsight | Johnson & Johnson, Alcon, Bausch & Lomb, ZEISS Group, STAAR Surgical, Hoya Corporation

The global Intraocular Lens (IOL) market, valued at USD 4,648.96 million in 2024, is projected to reach USD 7,414.66 million by 2032, driven by increasing eye-related disorders, technological advancements, and rising awareness. Key players like Johnson & Johnson, Alcon, and Bausc

Tone
Neutral 50/100
Event
Market update
Published
22 Jun 2026 22:11
Source
Barchart.com
Stock Titan Direct company coverage

[Form 4] STAAR SURGICAL CO Insider Trading Activity

STAAR Surgical director Lilian Yansheng Zhou reported acquisition or exercise transactions in a Form 4 filing. Zhou received new equity awards, including options to purchase 5,572 shares at $29.12 and 3,091 restricted stock units, as part of the company’s annual non-employee dire

Tone
Neutral 50/100
Event
Deals and strategy
Published
22 Jun 2026 20:11
Source
Stock Titan
Stock Titan Direct company coverage

STAAR Surgical (STAA) adds 3.9M plan shares, elects board and ratifies BDO

STAAR Surgical Company's shareholders approved substantial measures at their 2026 Annual Meeting. They voted to increase the shares reserved for their Omnibus Equity Incentive Plan by 3.9 million, elected seven directors, and ratified BDO USA, P.C. as the independent public accou

Tone
Neutral 50/100
Event
Market update
Published
22 Jun 2026 20:11
Source
Stock Titan
Simply Wall Street Direct company coverage

STAAR Surgical (STAA) Stock Could Be 4.4% Undervalued Despite Its Rich P S Multiple

STAAR Surgical (STAA) is viewed as potentially 4.4% undervalued based on a fair value estimate of $29.67 compared to its current price of $28.37, despite a rich P/S multiple of 4.9x, which is higher than peers and the industry average. The company has strong cash reserves and no

Tone
Positive 62/100
Event
Balance sheet
Published
17 Jun 2026 01:39
Source
Simply Wall Street
Stock Titan Direct company coverage

Director Lilian Zhou of STAAR Surgical (STAA) receives 3,530-share stock award

STAAR Surgical director Lilian Yansheng Zhou was awarded 3,530 shares of common stock on June 12, 2026, as a grant or award-type transaction. The shares were valued at a weighted average price of $28.2904, based on multiple trades between $28.215 and $28.35. Following this acquis

Tone
Neutral 50/100
Event
Market update
Published
15 Jun 2026 20:38
Source
Stock Titan
Sahm Direct company coverage

STAAR Surgical’s Standout Q1 Raises Questions On Sustainability And Valuation

STAAR Surgical reported outstanding Q1 results with a 120% revenue increase year-on-year, significantly beating analyst estimates and demonstrating strong business momentum. Despite the strong performance, the stock's recent momentum is down 11.5% over the last 30 days, and its v

Tone
Positive 64/100
Event
Earnings
Published
14 Jun 2026 12:39
Source
Sahm
TradingView Direct company coverage

STAAR Surgical Company Stock 12‑Month Price Target Raised to $30.5, Implies 6% Upside

STAAR Surgical Company's average 12-month price target has been increased from $29.67 to $30.5 by 8 analysts, suggesting a 6% potential upside from its June 11 closing price. The consensus rating among 11 covering analysts has shifted to "Buy", comprising 3 Buys, 8 Holds, and 0 S

Tone
Positive 75/100
Event
Analyst action
Published
12 Jun 2026 04:09
Source
TradingView
StockStory Direct company coverage

Medical Devices & Supplies - Specialty Stocks Q1 Earnings: STAAR Surgical (NASDAQ:STAA) Firing on All Cylinders

STAAR Surgical (NASDAQ:STAA) reported strong Q1 earnings, with revenues up 120% year-on-year, significantly exceeding analyst expectations. This performance made it the top performer among its peers in the medical devices & supplies specialty sector, which as a group also saw rev

Tone
Positive 67/100
Event
Earnings
Published
11 Jun 2026 22:09
Source
StockStory
The Globe and Mail Direct company coverage

STAAR Surgical Raises Pay for Interim Co-CEO Andrews

STAAR Surgical (STAA) has increased the annual base salary of Interim Co-CEO and CFO Deborah Andrews from $512,000 to $575,000, and her target annual cash bonus from 55% to 60% of base salary, effective June 8, 2026. These adjustments reflect competitive market data and recogniti

Tone
Neutral 50/100
Event
Analyst action
Published
10 Jun 2026 23:38
Source
The Globe and Mail
MarketBeat Direct company coverage

CenterBook Partners LP Buys New Position in STAAR Surgical Company $STAA

CenterBook Partners LP has acquired a new position in STAAR Surgical Company, purchasing 177,974 shares valued at approximately $4.1 million in the fourth quarter. This move comes as STAAR Surgical reported strong quarterly earnings of $0.10 per share and revenue of $93.52 millio

Tone
Positive 63/100
Event
Earnings
Published
09 Jun 2026 21:40
Source
MarketBeat